JP2006510740A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006510740A5 JP2006510740A5 JP2005507039A JP2005507039A JP2006510740A5 JP 2006510740 A5 JP2006510740 A5 JP 2006510740A5 JP 2005507039 A JP2005507039 A JP 2005507039A JP 2005507039 A JP2005507039 A JP 2005507039A JP 2006510740 A5 JP2006510740 A5 JP 2006510740A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- ursodeoxycholic acid
- bleeding
- patient
- nervous system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 21
- 208000012902 Nervous system disease Diseases 0.000 claims 6
- 230000000740 bleeding effect Effects 0.000 claims 6
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 claims 5
- 208000016988 Hemorrhagic Stroke Diseases 0.000 claims 4
- 208000020658 intracerebral hemorrhage Diseases 0.000 claims 4
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 claims 3
- 229960001661 ursodiol Drugs 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 238000007911 parenteral administration Methods 0.000 claims 2
- 208000033808 peripheral neuropathy Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 230000008736 traumatic injury Effects 0.000 claims 2
- GHCZAUBVMUEKKP-NHIHLBCISA-N 2-[[(4R)-4-[(3R,5S,7S,10S,13R,17R)-3,7-Dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)C1C2C2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)CC1 GHCZAUBVMUEKKP-NHIHLBCISA-N 0.000 claims 1
- 208000029033 Spinal Cord disease Diseases 0.000 claims 1
- BHTRKEVKTKCXOH-UHFFFAOYSA-N Taurochenodesoxycholsaeure Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)CC2 BHTRKEVKTKCXOH-UHFFFAOYSA-N 0.000 claims 1
- 239000003613 bile acid Substances 0.000 claims 1
- 208000020431 spinal cord injury Diseases 0.000 claims 1
- BHTRKEVKTKCXOH-LBSADWJPSA-N tauroursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)CC1 BHTRKEVKTKCXOH-LBSADWJPSA-N 0.000 claims 1
- 239000003020 ursodeoxycholic acid derivative Substances 0.000 claims 1
- GHCZAUBVMUEKKP-UHFFFAOYSA-N ursodeoxycholic acid glycine-conjugate Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)CC2 GHCZAUBVMUEKKP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42521002P | 2002-11-07 | 2002-11-07 | |
| US45161503P | 2003-03-03 | 2003-03-03 | |
| PCT/US2003/031989 WO2004043342A2 (en) | 2002-11-07 | 2003-10-08 | Methods of treating injuries of the nervous system associated with hemorrhage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006510740A JP2006510740A (ja) | 2006-03-30 |
| JP2006510740A5 true JP2006510740A5 (enExample) | 2006-11-24 |
Family
ID=32314576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005507039A Pending JP2006510740A (ja) | 2002-11-07 | 2003-10-08 | 出血と関連した神経系障害を治療する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20060135494A1 (enExample) |
| EP (1) | EP1575578B1 (enExample) |
| JP (1) | JP2006510740A (enExample) |
| KR (1) | KR20050103185A (enExample) |
| AT (1) | ATE451108T1 (enExample) |
| AU (1) | AU2003275495A1 (enExample) |
| DE (1) | DE60330501D1 (enExample) |
| WO (1) | WO2004043342A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7772220B2 (en) | 2004-10-15 | 2010-08-10 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
| US20030044413A1 (en) * | 2000-08-15 | 2003-03-06 | Regents Of The University Of Minnesota | Methods of limiting apoptosis of cells |
| US20060204481A1 (en) * | 2003-04-02 | 2006-09-14 | Steer Clifford J | Methods of promoting cell viability |
| CN101035541B (zh) * | 2004-08-30 | 2012-05-30 | 柳署弘 | 溶解的udca在局灶缺血模型中的神经保护作用 |
| AU2005295541B2 (en) | 2004-10-15 | 2011-02-17 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
| US20080194531A1 (en) * | 2005-02-10 | 2008-08-14 | Steer Clifford J | Methods for Treating Visual Disorders |
| CN101534641A (zh) * | 2006-03-22 | 2009-09-16 | 哈佛大学校长及研究员协会 | 治疗高胆固醇血症和动脉粥样硬化的方法和组合物 |
| KR20180029317A (ko) * | 2016-09-12 | 2018-03-21 | 경상대학교산학협력단 | 간손상 예방, 개선 또는 치료용 조성물 |
| KR101953298B1 (ko) * | 2017-07-18 | 2019-02-28 | 의료법인 성광의료재단 | 우르소데옥시콜산을 함유하는 염증성 질환 또는 척수 손상 예방 또는 치료용 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2090876A1 (en) * | 1991-07-03 | 1993-01-04 | Satoru Nakai | Apoptosis regulating composition |
| US5656725A (en) * | 1995-05-12 | 1997-08-12 | Apoptosis Technology, Inc. | Peptides and compositions which modulate apoptosis |
| US6544972B1 (en) * | 1997-09-25 | 2003-04-08 | Regents Of The University Of Minnesota | Methods of limiting apoptosis of cells |
| US6555141B1 (en) * | 1998-02-27 | 2003-04-29 | Nutramax Laboratories, Inc. | L-ergothioneine, Milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage |
| GB0019290D0 (en) * | 2000-08-04 | 2000-09-27 | Symphar Sa | Methods for inducing apolipoprotein E secretion |
| US20030044413A1 (en) * | 2000-08-15 | 2003-03-06 | Regents Of The University Of Minnesota | Methods of limiting apoptosis of cells |
-
2003
- 2003-10-08 JP JP2005507039A patent/JP2006510740A/ja active Pending
- 2003-10-08 WO PCT/US2003/031989 patent/WO2004043342A2/en not_active Ceased
- 2003-10-08 DE DE60330501T patent/DE60330501D1/de not_active Expired - Lifetime
- 2003-10-08 AT AT03759773T patent/ATE451108T1/de not_active IP Right Cessation
- 2003-10-08 AU AU2003275495A patent/AU2003275495A1/en not_active Abandoned
- 2003-10-08 KR KR1020057008192A patent/KR20050103185A/ko not_active Withdrawn
- 2003-10-08 US US10/532,039 patent/US20060135494A1/en not_active Abandoned
- 2003-10-08 EP EP03759773A patent/EP1575578B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021100937A5 (enExample) | ||
| JP2005508338A5 (enExample) | ||
| EP3332797A3 (en) | Therapeutic effects of bryostatins, bryologs and other related substances on head trauma-induced memory impairment and brain injury | |
| CA2066403A1 (en) | Transmucosal dosage form | |
| EP2269647A3 (de) | Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika | |
| ITRM960479A1 (it) | Uso della acetil l-carnitina, della isovaleril l-carnitina, della pro= pionil l-carnitina o dei loro sali farmacologicamente accettabili per | |
| JP2003516325A5 (enExample) | ||
| JP2005537268A5 (enExample) | ||
| RU2007101039A (ru) | Иммуностимулирующие олигонуклеотидные мультимеры | |
| JP2005500357A5 (enExample) | ||
| EP2746251A3 (en) | Positively charged water-soluble prodrugs of acetaminophen and related compunds with very fast skin penetration rate | |
| RU2002127804A (ru) | Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения | |
| JP2006510740A5 (enExample) | ||
| WO1993000083A1 (en) | Pharmaceutical composition containing gamma-hydroxybutyric acid or its lactone in the treatment of drug dependence and nutritional disorders | |
| JP2005506275A5 (enExample) | ||
| JP2009517411A5 (enExample) | ||
| JP2006515370A5 (enExample) | ||
| CA2401000A1 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
| JP2009500045A5 (enExample) | ||
| JP2006514681A5 (enExample) | ||
| IL194500A (en) | A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above | |
| US20100029771A1 (en) | Treatment of addictive disorders | |
| JP2002530353A5 (enExample) | ||
| EP2382982A3 (en) | Neural regeneration peptide and methods for their use in treatment of brain damage | |
| WO2001012214A3 (en) | MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a) |